Found 125 matching trials
Cetuximab + BYL719 + IMRT (Intensity-Modulated Radiation Therapy) in Stage III/IVB Head and Neck Squamous Cell Cancer (HNSCC) PHASE1 This is a phase 1b study, which means that the purpose of the study is to e...
Show More Location
Memorial Sloan Kettering Cancer Center at Basking Ridge
Learn More & Join Trial
Lenalidomide and Cetuximab in Patients With Advanced Solid Tumors PHASE1 This is a Phase 1/2, open-label, monocentric, dose-escalation study of lena...
Show More Location
Medical University of Innsbruck, Department for Internal Medicine I
Learn More & Join Trial
A Study of BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors PHASE1 The purpose of this study is to find a safe, tolerable, and efficacious dos...
Show More Location
Local Institution - 0047
Learn More & Join Trial
Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer PHASE1 The purpose of this study is to determine if a new drug, RO4929097, can wor...
Show More Location
Vanderbilt University/Ingram Cancer Center
Learn More & Join Trial
Study of AUBE00 in Patients With Solid Tumors PHASE1 This is a first-in-human, Phase I, open-label, multicenter, multinational s...
Show More Location
South Texas Accelerated Research Therapeutics (START) Midwest
Learn More & Join Trial
LEAC-102 for Advanced Colorectal Cancer PHASE1 A Phase I/IIa Dose-Escalation Study Evaluating the Safety, Tolerability and...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck PHASE1 The objective of this study is to evaluate in a 3 +3 design, the safety of ...
Show More Location
University of California, Moores Cancer Center
Learn More & Join Trial
Safety, Immunogenicity and Pharmacokinetics of SYN004 in Patients With Solid Tumors PHASE1 A first-in-human evaluation of SYN004, a monoclonal antibody that binds to ...
Show More Location
Ochsner Medical Center
Learn More & Join Trial
BBO-11818 in Adult Subjects With KRAS Mutant Cancer PHASE1 A first in human study to evaluate the safety and preliminary antitumor act...
Show More Location
The Angeles Clinic and Research Institute - West Los Angeles Office
Learn More & Join Trial
CGX1321 in Subjects With Advanced Solid Tumors and CGX1321 With Pembrolizumab or Encorafenib + Cetuximab in Subjects With Advanced GI Tumors (Keynote 596) PHASE1 This is a multicenter, open-label study conducted in two phases: Phase 1 co...
Show More Learn More & Join Trial